NEUTRALIZING ANTI-SARS-COV-2 ANTIBODIES
This disclosure provides novel neutralizing anti-SARS-CoV-2 antibodies or antigen-binding fragments thereof. The disclosed anti-SARS-CoV-2 antibodies constitute a novel therapeutic strategy in protection from SARS-CoV-2 infections..
| Media Type: |
Electronic Article |
|---|
| Year of Publication: |
2023 |
|---|---|
| Publication: |
2023 |
| Contained In: |
Europäisches Patentamt - (2023) vom: 22. Nov. To Main Record - year:2023 |
|---|
| Language: |
English |
|---|
| Contributors: |
NUSSENZWEIG MICHEL [Author] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Notes: |
Source: www.epo.org (no modifications made), First posted: 2023-11-22, Last update posted on www.tib.eu: 2024-03-05, Last updated: 2024-03-08 |
|---|
| Patent number: |
EP4277926 |
|---|
| Supporting institution / Project title: |
|
|---|
| PPN (Catalogue-ID): |
EPA018649998 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA018649998 | ||
| 003 | DE-627 | ||
| 005 | 20240308100522.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231201s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA018649998 | ||
| 035 | |a (EPA)EP4277926 | ||
| 035 | |a (EPA)80168130 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a NUSSENZWEIG MICHEL |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a NEUTRALIZING ANTI-SARS-COV-2 ANTIBODIES |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-11-22, Last update posted on www.tib.eu: 2024-03-05, Last updated: 2024-03-08 | ||
| 520 | |a This disclosure provides novel neutralizing anti-SARS-CoV-2 antibodies or antigen-binding fragments thereof. The disclosed anti-SARS-CoV-2 antibodies constitute a novel therapeutic strategy in protection from SARS-CoV-2 infections. | ||
| 650 | 4 | |a tec | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a G01N: Investigating or analysing materials by determining their chemical or physical properties (measuring or testing processes other than immunoassay, involving enzymes or microorganisms c12m, c12q) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000) | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a WANG ZIJUN |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 22. Nov. |
| 773 | 1 | 8 | |g year:2023 |g day:22 |g month:11 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/80168130/publication/EP4277926A1?q=EP4277926 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 22 |c 11 | ||